GMP Manufacturing and IND-Enabling Studies of a Recombinant Hyperimmune Globulin Targeting SARS-CoV-2
Rena A. Mizrahi, Wendy Y. Lin,Ashley Gras,Ariel R. Niedecken,Ellen K. Wagner,Sheila M. Keating, Nikita Ikon,Vishal A. Manickam,Michael A. Asensio,Jackson Leong,Angelica Medina-Cucurella,Emily Benzie,Kyle P. Carter,Yao Chiang, Robert C. Edgar,Renee Leong,Yoong Wearn Lim,Jan Fredrik Simons,Matthew J. Spindler,Kacy Stadtmiller,Nicholas Wayham,Dirk Buscher,Jose Vicente Terencio,Clara Di Germanio,Steven M. Chamow,Charles Olson,Paula A. Pino,Jun-Gyu Park,Amberlee Hicks,Chengjin Ye,Andreu Garcia-Vilanova,Luis Martinez-Sobrido,Jordi B. Torrelles,David S. Johnson,Adam S. Adler Pathogens（2022）
Key words
recombinant hyperimmune,GMP manufacturing,SARS-CoV-2
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper